6-Chloro-3-methyluracil

6-Chloro-3-methyluracil (CAS 4318-56-3) is a pharmaceutical-grade uracil derivative used both as an intermediate for alogliptin, an oral antihyperglycemic agent, and in the synthesis of antibacterial agents targeting Helicobacter pylori glutamate racemase inhibitors. It is manufactured directly by Hunan HuaTeng Pharmaceutical Co., Ltd. to the supplier's in-house standard, and sold into North America, Central/South America, Western and Eastern Europe, Australasia and Asia.